Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 2373-2385

  Tsai, Pei Fang ^a   Lin, Sue Jane ^b   Weng, Pei Lun ^a   Tsai, Shu Chun ^a   Lin, Jiun Han ^a   Chou, Ya Ching ^a   Tsai, Ching Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITOR; IMMEDIATE EARLY PROTEIN BZLF1; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; ROTTERLIN; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVATION; ENZYME RELEASE; EPSTEIN BARR VIRUS; GENE DELETION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS EXPRESSION; VIRUS REACTIVATION;

CELL LINE; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMEDIATE-EARLY PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASE C-DELTA; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 79551699531     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01602-10     Document Type: Article

References (61)

1. Al-Sarraj, A., R. M. Day, and G. Thiel. 2005. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1. J. Cell Biochem. 94:153-167. (Pubitemid 41420333)
2. Borras, A. M., J. L. Strominger, and S. H. Speck. 1996. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J. Virol. 70:3894-3901.
3. Chang, L. K., and S. T. Liu. 2000. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res. 28:3918-3925.
4. Chang, S. S., et al. 2008. Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression. J. Virol. 82:7745-7751.
5. Chang, Y., et al. 2006. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J. Virol. 80:7748-7755. (Pubitemid 44092594)
6. Chang, Y., et al. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866. (Pubitemid 29441755)
7. Chang, Y. C., S. Illenye, and N. H. Heintz. 2001. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. Mol. Cell. Biol. 21:1121-1131.
8. Chien, Y. C., et al. 2001. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 345:1877-1882.
9. Chou, C. W., and C. C. Chen. 2008. HDAC inhibition upregulates the expression of angiostatic ADAMTS1. FEBS Lett. 582:4059-4065.
10. Chu, S., and T. J. Ferro. 2005. Sp1: regulation of gene expression by phosphorylation. Gene 348:1-11.
11. Chua, H. H., et al. 2007. Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J. Virol. 81:2459-2471.
12. Chun, R. F., O. J. Semmes, C. Neuveut, and K. T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629.
13. Cohen, A., C. Brodie, and R. Sarid. 2006. An essential role of ERK signaling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol. 87:795-802.
14. Daibata, M., S. H. Speck, C. Mulder, and T. Sairenji. 1994. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology 198:446-454.
15. Davies, A. H., R. J. Grand, F. J. Evans, and A. B. Rickinson. 1991. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C. J. Virol. 65:6838-6844.
16. Deutsch, E., et al. 2004. Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus. J. Virol. 78:10187-10192. (Pubitemid 39187136)
17. Flamand, L., and J. Menezes. 1996. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J. Virol. 70:1784-1791. (Pubitemid 26062940)
18. Flemington, E., and S. H. Speck. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
19. Flemington, E., and S. H. Speck. 1990. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1217-1226.
20. Gao, J., et al. 2009. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-trichostatin A through Sp1 binding site. Glia 57:989-999.
21. Gao, X., K. Ikuta, M. Tajima, and T. Sairenji. 2001. 12-O- tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-κB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286:91-99. (Pubitemid 32675469)
22. Glaser, G., M. Vogel, H. Wolf, and H. H. Niller. 1998. Regulation of the Epstein-Barr viral immediate-early BRLF1 promoter through a distal NF1 site. Arch. Virol. 143:1967-1983.
23. Gruffat, H., E. Manet, and A. Sergeant. 2002. MEF2-mediated recruitment of class II HDAC at the EBV immediate-early gene BZLF1 links latency and chromatin remodeling. EMBO Rep. 3:141-146. (Pubitemid 34213491)
24. Huang, W., et al. 2005. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280:10047-10054.
25. Itoh, Y., et al. 2007. 17beta-estradiol induces IL-1alpha gene expression in rheumatoid fibroblast-like synovial cells through estrogen receptor alpha (ERα) and augmentation of transcriptional activity of Sp1 by dissociating histone deacetylase 2 from ERα. J. Immunol. 178:3059-3066. (Pubitemid 46333186)
26. Jiang, G., A. Espeseth, D. J. Hazuda, and D. M. Margolis. 2007. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81:10914-10923.
27. Juan, L. J., et al. 2000. Histone deacetylases specifically downregulate p53-dependent gene activation. J. Biol. Chem. 275:20436-20443.
28. Kim, T. Y., et al. 2008. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. Exp. Mol. Med. 40:639-646.
29. Kim, Y. H., J. H. Lim, T. J. Lee, J. W. Park, and T. K. Kwon. 2007. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-δ) signal pathway. J. Cell Biochem. 101:987-995.
30. Lavens, S., et al. 2004. Identification of protein tyrosine kinases required for B-cell-receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter. J. Virol. 78:8543-8551. (Pubitemid 39025120)
31. Lee, H. H., et al. 2008. Essential role of PKCδ in histone deacetylase inhibitor-induced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells. J. Gen. Virol. 89:878-883.
32. Lin, C. T., et al. 1993. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab. Invest. 68:716-727.
33. Lin, J. C., et al. 2004. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med. 350:2461-2470.
34. Lin, Y. C., et al. 2008. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Cancer Res. 68:2375-2383.
35. Liu, S., A. M. Borras, P. Liu, G. Suske, and S. H. Speck. 1997. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228:11-18.
36. Liu, S., P. Liu, A. Borras, T. Chatila, and S. H. Speck. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-153.
37. MacCallum, P., L. Karimi, and L. J. Nicholson. 1999. Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells. J. Gen. Virol. 80(Pt. 6):1501-1512.
38. Manet, E., et al. 1989. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional transactivators. EMBO J. 8:1819-1826. (Pubitemid 19273999)
39. McDonald, C., C. Elgueta Karstegl, P. Kellam, and P. J. Farrell. 2010. Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency. J. Gen. Virol. 91:622-629.
40. Minucci, S., and P. G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6:38-51.
41. Newton, A. C. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101:2353-2364.
42. Petersohn, D., and G. Thiel. 1996. Role of zinc-finger proteins Sp1 and zif268/egr-1 in transcriptional regulation of the human synaptobrevin II gene. Eur. J. Biochem. 239:827-834.
43. Piovan, E., et al. 2003. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia 17:1643-1649. (Pubitemid 36986968)
44. Safe, S., and M. Abdelrahim. 2005. Sp transcription factor family and its role in cancer. Eur. J. Cancer 41:2438-2448. (Pubitemid 41540621)
45. Shimizu, N., and K. Takada. 1993. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. J. Virol. 67:3240-3245. (Pubitemid 23143695)
46. Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405. (Pubitemid 27417826)
47. Tan, N. Y., and L. M. Khachigian. 2009. Sp1 phosphorylation and its regulation of gene transcription. Mol. Cell. Biol. 29:2483-2488.
48. Tarodi, B., T. Subramanian, and G. Chinnadurai. 1994. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology 201:404-407. (Pubitemid 24187289)
49. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
50. Tsai, S. C., et al. 2009. EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines. Blood 114:109-118.
51. Wang, Y. C., J. M. Huang, and E. A. Montalvo. 1997. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227:323-330.
52. Wierstra, I. 2008. Sp1: emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372:1-13.
53. Won, J., J. Yim, and T. K. Kim. 2002. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem. 277:38230-38238.
54. Wu, F. Y., et al. 2004. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. J. Virol. 78:4847-4865. (Pubitemid 38501105)
55. Ye, J., D. Shedd, and G. Miller. 2005. An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate. J. Virol. 79:1397-1408. (Pubitemid 40459087)
56. Yi, T., et al. 2007. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. Exp. Mol. Med. 39:213-221.
57. Yokota, T., et al. 2004. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene 23:5340-5349. (Pubitemid 39005809)
58. Zalani, S., A. Coppage, E. Holley-Guthrie, and S. Kenney. 1997. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter. J. Virol. 71:3268-3274. (Pubitemid 27119977)
59. Zalani, S., E. Holley-Guthrie, and S. Kenney. 1995. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter. J. Virol. 69:3816-3823.
60. Zalani, S., E. A. Holley-Guthrie, D. E. Gutsch, and S. C. Kenney. 1992. The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J. Virol. 66:7282-7292.
61. Zhang, Y., M. Liao, and M. L. Dufau. 2006. Phosphatidylinositol 3-kinase/protein kinase Cζ-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression of transcription of the luteinizing hormone receptor gene. Mol. Cell. Biol. 26:6748-6761.